We are live on ! Find out more
LBPS

4D Pharma PLC

Delisted

LBPS was delisted on the 24th of June, 2022.

8 hedge funds and large institutions have $430K invested in 4D Pharma PLC in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 108 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

79% less capital invested

Capital invested by funds: $2.03M → $430K (-$1.6M)

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RL
1
Ruffer LLP
United Kingdom
$320K
Citadel Advisors
2
Citadel Advisors
Florida
$46K -$11.5K -3,372 -11%
Capstone Investment Advisors
3
Capstone Investment Advisors
New York
$25K
WAM
4
Wolverine Asset Management
Illinois
$13K
TRCT
5
Tower Research Capital (TRC)
New York
$8K -$13.1K -3,863 -45%
Osaic Holdings
6
Osaic Holdings
Arizona
$8K +$1.78K +525 +12%
Morgan Stanley
7
Morgan Stanley
New York
$7K -$133K -39,003 -90%
CS
8
Credit Suisse
Switzerland
$3K +$5.57K +1,638 New
KC
9
Kepos Capital
New York
-$483K -100,000 Closed
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
-$57K -11,845 Closed
UBS Group
11
UBS Group
Switzerland
-$10K -2,155 Closed

LBPS Hedge Fund Activity: Q2 2022 in Review

8 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC (LBPS) for Q2 2022, worth a combined $430K — down 79% from $2.03M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LBPS and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Credit Suisse, opening a new position worth an estimated $5.57K. The largest seller was Kepos Capital, exiting entirely with an estimated $483K sold.

  • 8 institutional investors held 4D Pharma PLC (LBPS) as of Q2 2022, down from 10 in Q1 2022.
  • Funds reported $430K of 4D Pharma PLC stock for Q2 2022, down 79% quarter-over-quarter.
  • 1 fund opened new 4D Pharma PLC positions in Q2 2022 and 3 closed out, a net change of -2 holders.
  • The largest 4D Pharma PLC buyer in Q2 2022 was Credit Suisse, an estimated $5.57K added.
  • The largest 4D Pharma PLC seller in Q2 2022 was Kepos Capital, an estimated $483K sold.

Based on aggregated 13F filings for Q2 2022.